CARGO Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Net Income	-98.15	-40.95	-5.85
Depreciation & Amortization	3.69	1.44	0.15
Share-Based Compensation	3.33	0.3	0.51
Other Operating Activities	9.96	10.14	0.25
Operating Cash Flow	-81.16	-29.07	-4.94
Capital Expenditures	-8.28	-2.72	-0.44
Other Investing Activities	-0.72	-0.56	-
Investing Cash Flow	-8.99	-3.28	-0.44
Share Issuance / Repurchase	291.17	0.23	0
Debt Issued / Paid	3.5	28.45	0
Other Financing Activities	199.92	5.5	5.41
Financing Cash Flow	494.58	34.19	5.41
Net Cash Flow	404.43	1.83	0.03
Free Cash Flow	-89.44	-31.8	-5.38
Free Cash Flow Per Share	-15.06	-81.06	-2.60

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).